ID: ALA3331374

Max Phase: Preclinical

Molecular Formula: C15H15N4O9P

Molecular Weight: 426.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=Cc1ccc(-c2ncnc3c2ncn3[C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)o1

Standard InChI:  InChI=1S/C15H15N4O9P/c20-3-7-1-2-8(27-7)10-11-14(17-5-16-10)19(6-18-11)15-13(22)12(21)9(28-15)4-26-29(23,24)25/h1-3,5-6,9,12-13,15,21-22H,4H2,(H2,23,24,25)/t9-,12-,13-,15-/m1/s1

Standard InChI Key:  XLSXTKPMEVPFCI-QGMIFYJMSA-N

Associated Targets(Human)

DNPH1 Tchem 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 426.28Molecular Weight (Monoisotopic): 426.0577AlogP: -0.37#Rotatable Bonds: 6
Polar Surface Area: 190.26Molecular Species: ACIDHBA: 11HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.22CX Basic pKa: 0.81CX LogP: -1.77CX LogD: -4.78
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.30Np Likeness Score: 0.84

References

1. Amiable C, Paoletti J, Haouz A, Padilla A, Labesse G, Kaminski PA, Pochet S..  (2014)  6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.,  85  [PMID:25108359] [10.1016/j.ejmech.2014.07.110]

Source